251 related articles for article (PubMed ID: 1376378)
1. Role of autocrine and paracrine production of granulocyte-macrophage colony-stimulating factor and interleukin-1 beta in the autonomous growth of acute myeloblastic leukaemia cells--studies using purified CD34-positive cells.
Bradbury D; Rogers S; Reilly IA; Kozlowski R; Russell NH
Leukemia; 1992 Jun; 6(6):562-6. PubMed ID: 1376378
[TBL] [Abstract][Full Text] [Related]
2. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
Carlo-Stella C; Mangoni L; Almici C; Frassoni F; Fiers W; Rizzoli V
Leukemia; 1990 Aug; 4(8):561-6. PubMed ID: 1697011
[TBL] [Abstract][Full Text] [Related]
3. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
Delwel R; van Buitenen C; Salem M; Oosterom R; Touw I; Löwenberg B
Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834
[TBL] [Abstract][Full Text] [Related]
4. Evidence for internal autocrine regulation of growth in acute myeloblastic leukemia cells.
Rogers SY; Bradbury D; Kozlowski R; Russell NH
Exp Hematol; 1994 Jul; 22(7):593-8. PubMed ID: 7516889
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Bcl-2 expression and apoptosis in acute myeloblastic leukaemia cells by granulocyte-macrophage colony-stimulating factor.
Bradbury D; Zhu YM; Russell N
Leukemia; 1994 May; 8(5):786-91. PubMed ID: 8182935
[TBL] [Abstract][Full Text] [Related]
6. Endogenous interleukin-1 can regulate the autonomous growth of the blast cells of acute myeloblastic leukemia by inducing autocrine secretion of GM-CSF.
Bradbury D; Bowen G; Kozlowski R; Reilly I; Russell N
Leukemia; 1990 Jan; 4(1):44-7. PubMed ID: 2404162
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 production by the blast cells of acute myeloblastic leukemia: regulation by endogenous interleukin-1 and biological implications.
Beauchemin V; Villeneuve L; Rodriguez-Cimadevilla JC; Rajotte D; Kenney JS; Clark SC; Hoang T
J Cell Physiol; 1991 Sep; 148(3):353-61. PubMed ID: 1918169
[TBL] [Abstract][Full Text] [Related]
8. Coordinate secretion of interleukin-1 beta and granulocyte-macrophage colony-stimulating factor by the blast cells of acute myeloblastic leukemia: role of interleukin-1 as an endogenous inducer.
Rodriguez-Cimadevilla JC; Beauchemin V; Villeneuve L; Letendre F; Shaw A; Hoang T
Blood; 1990 Oct; 76(8):1481-9. PubMed ID: 2207323
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 is one factor which regulates autocrine production of GM-CSF by the blast cells of acute myeloblastic leukaemia.
Bradbury D; Rogers S; Kozlowski R; Bowen G; Reilly IA; Russell NH
Br J Haematol; 1990 Dec; 76(4):488-93. PubMed ID: 2265111
[TBL] [Abstract][Full Text] [Related]
10. Differential responses of CD34-positive acute myelogenous leukemic blasts to the costimulating effects of stem cell factor with GM-CSF and/or IL-3.
Min YH; Lee ST; Lee BK; Chong SY; Lee S; Hahn JS; Ko YW
Yonsei Med J; 1995 Mar; 36(1):26-36. PubMed ID: 7537932
[TBL] [Abstract][Full Text] [Related]
11. Absence of retinoblastoma protein expression results in autocrine production of interleukin-6 and promotes the autonomous growth of acute myeloid leukemia blast cells.
Zhu YM; Bradbury DA; Keith FJ; Russell N
Leukemia; 1994 Nov; 8(11):1982-8. PubMed ID: 7967742
[TBL] [Abstract][Full Text] [Related]
12. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.
te Boekhorst PA; Löwenberg B; Vlastuin M; Sonneveld P
Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839
[TBL] [Abstract][Full Text] [Related]
13. Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control.
Oster W; Cicco NA; Klein H; Hirano T; Kishimoto T; Lindemann A; Mertelsmann RH; Herrmann F
J Clin Invest; 1989 Aug; 84(2):451-7. PubMed ID: 2788173
[TBL] [Abstract][Full Text] [Related]
14. Enhancement by transforming growth factor-beta 1 (TGF-beta 1) of the proliferation of leukemic blast progenitors stimulated with IL-3.
Suzuki T; Bessho M; Hirashima K; Tohda S; Nagata K; Morio T; Imai Y; Nara N
J Cell Physiol; 1991 Sep; 148(3):396-403. PubMed ID: 1717497
[TBL] [Abstract][Full Text] [Related]
15. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
[TBL] [Abstract][Full Text] [Related]
16. IL-3 inhibits the binding of GM-CSF to AML blasts, but the two cytokines act synergistically in supporting blast proliferation.
Onetto-Pothier N; Aumont N; Haman A; Park L; Clark SC; De Léan A; Hoang T
Leukemia; 1990 May; 4(5):329-36. PubMed ID: 2201826
[TBL] [Abstract][Full Text] [Related]
17. Modulation of colony stimulating factor-(CSF) dependent growth of acute myeloid leukemia by tumor necrosis factor.
Salem M; Delwel R; Touw I; Mahmoud LA; Elbasousy EM; Löwenberg B
Leukemia; 1990 Jan; 4(1):37-43. PubMed ID: 1688638
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor alpha modulates the messenger RNA expression of hematopoietic growth factor genes in fresh blast cells from patients with acute myeloblastic leukemia.
Bergamaschi G; Cazzola M; Rosti V; Carlo-Stella C; Santini V; Ponchio L; Peverali FA; Della Valle G; Rossi Ferrini P; Ascari E
Leukemia; 1991 Oct; 5(10):886-91. PubMed ID: 1961022
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of interleukin 1 on the progenitors of blast cells in acute myeloblastic leukemia.
Murohashi I; Tohda S; Suzuki T; Nagata K; Yamashita Y; Nara N
Exp Hematol; 1990 Feb; 18(2):133-7. PubMed ID: 2406155
[TBL] [Abstract][Full Text] [Related]
20. The effects of IL-1 beta and IL-4 on the proliferation and endogenous secretion of growth factors by acute myeloblastic leukemic cells.
Wagteveld AJ; Esselink MT; Limburg P; Halie MR; Vellenga E
Leukemia; 1992 Oct; 6(10):1020-4. PubMed ID: 1405754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
